AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sita-Glutaryl M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Vakula Health Care Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sita-Glutaryl M 50/500 Tablet

Gluco-Dual 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lessening heart attack or stroke risk. Gluco-Dual 50/500 may be used independently or with other diabetes treatments. Optimal results require a balanced diet and regular physical activity. Dosage is individualized based on your health, blood sugar readings, and other medications. Consuming the tablets with meals minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and throat irritation. Low blood sugar (hypoglycemia) is possible, especially with concurrent use of insulin or sulfonylureas; learn how to identify and manage this. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting treatment. Pregnant or nursing women should consult their doctor. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effects. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Primary Ingredients of Sita-Glutaryl M 50/500 Tablet

No text provided to rephrase.

Uses of Sita-Glutaryl M 50/500 Tablet

Managing Type 2 Diabetes

Major Benefits of Sita-Glutaryl M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sita-Glutaryl M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

Common Side effects of Sita-Glutaryl M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sita-Glutaryl M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Sita-Glutaryl M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

How Sita-Glutaryl M 50/500 Tablet works:

Sita-Glutaryl M 50/500 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sita-Glutaryl M 50/500 Tablet is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sita-Glutaryl M 50/500 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sita-Glutaryl M 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the medication Sita-Glutaryl M 50/500 Tablet cautiously, potentially requiring dosage modification. Medical advice is essential. Sita-Glutaryl M 50/500 Tablet is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sita-Glutaryl M 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sita-Glutaryl M 50/500 Tablet :

Should you forget a dose of Sita-Glutaryl M 50/500 Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sita-Glutaryl M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sita-Glutaryl M 50/500 Tablet

Sita-Glutaryl M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sita-Glutaryl M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sita-Glutaryl M 50/500 Tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may result in vitamin B12 deficiency.
Patients with allergies to Sita-Glutaryl M 50/500 Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sita-Glutaryl M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sita-Glutaryl M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sita-Glutaryl M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sita-Glutaryl M 50/500 Tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sita-Glutaryl M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sita-Glutaryl M 50/500 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (like Sita-Glutaryl M 50/500) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sita-Glutaryl M 50/500 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sita-Glutaryl M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sita-Glutaryl M 50/500 Tablet may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with allergies to Sita-Glutaryl M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sita-Glutaryl M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sita-Glutaryl M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms occur.
Prolonged use of Sita-Glutaryl M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sita-Glutaryl M 50/500 Ta...
194